Treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson's disease

International Journal of Neuroscience

Volumn 97, Issue 3-4, 1999, Pages 225-233

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Electromagnetic fields; Olfactory bulb; Olfactory dysfunction; Parkinson's disease; Postsynaptic dopamine D2 receptors; Yawning

Indexed keywords

EID: 0033120225     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459909000662     Document Type: Article

References (43)

1. Argiolas, A. & Melis, M. R. (1998) The neuropharmacology of yawning. European Journal of Pharmacology, 343, 1-16.
2. Baenninger, R., Binkley, S. & Baenninger, M. (1996) Field observations of yawning and activity in humans. Physiology and Behavior, 59, 421-425.
3. Blackman, C. F., Benane, S. G., House, D. E. & Elliott, D. J. (1990) Importance of alignment between local DC magnetic field and an oscillating magnetic field in responses of brain tissue in vitro and in vivo. Bioelectromagnetics, 11, 159-167.
4. Blin, O., Masson, G., Azulay, J. P., Fondarai, J. & Serratrice, G. (1990) Apomorphine-indued blinking and yawning in healthy volunteers. British Journal of Clinical Pharmacology, 30, 769-773.
5. Blin, O., Azulay, J. P., Masson, G. & Serratrice, G. (1991) Yawning. Physiopathology and neuropharmacology. Therapie, 46, 37-43.
6. Charuchinda, C., Supavilai, P., Karobath, M. & Palacios, J. M. (1987) Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand. Journal of Neuroscience, 7, 1352-1360.
7. Coronas, V., Srivastava, L. K., Liang, J. J., Jourdan, F. & Moyse, E. (1997) Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach. Journal of Chemical Neuroanatomy, 12, 243-257.
8. Doty, R. L., Deems, D. A. & Stellar, S. (1988) Olfactory dysfunction in Parkinsonism: a general deficit unrelated □çto neurologic signs, disease stage or disease duration. Neurology, 38, 1237-1244.
9. Doty, R. L., Riklan, M., Deems, D. A., Reynolds, C. & Stellar, S. (1989) The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Annals of Neurology, 25, 166-171.
10. Doty, R. L., Stern, M. B., Pfeiffer, C., Gollomp, S. M. & Hurtig, H. I. (1992a) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 55, 138-142.
11. Doty, R. L., Singh, A., Tetrud, J. & Langston, J. W. (1992b) Lack of major olfactory dysfunction in MPTP-induced Parkinsonism. Annals of Neurology, 32, 97-100.
12. Doty, R. L., Bromley, S. M. & Stern, M. B. (1995) Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration, 4, 93-97.
13. Dubocovich, M. L. & Hensler, J. G. (1986) Modulation of 3H-dopamine released by different frequencies of stimulation from rabbit retina. British Journal of Pharmacology, 88, 51-61.
14. Goren, J. L. & Friedman, J. H. (1998) Yawning as an aura for an L-dopa-induced 'on' in Parkinson's disease. Neurology, 50, 823.
15. Guthrie, K. M., Pullara, J. M., Marshall, J. F. & Leon, M. (1991) Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb. Synapse, 8, 61-70.
16. Halasz, N., Ljungdahl, A., Hokfelt, T., Johansson, O., Goldstein, M., Park, D. & Biberfeld, P. (1977) Transmitter histochemistry of the rat olfactory bulb: I. immunohistochemical localization of monoamine synthesizing enzymes. Support for intrabulbar, periglomerular dopamine neurons. Brain Research, 126, 455-474.
17. Hawkes, C. H., Shephard, B. C. & Daniel, S. E. (1997) Olfactory dysfunction in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 62, 436-446.
18. Hoehn, M. M. & Yahr, M. D. (1967) Parkinsonism: onset, progression and mortality. Neurology, 17, 427-442.
19. Kato, T., Otsu, Y., Furune, Y. & Yamamoto, T. (1992) Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats. Neurochemistry International, 21, 99-107.
20. Kavaliers, M. & Ossenkopp, K. P. (1987) Calcium channel involvement in magnetic field inhibition of morphie-induced analcesia. Naunyn Schmiedebergs Archives of Pharmacology, 336, 308-315.
21. Korten, J. J. & Meulstee, J. (1980) Olfactory disturbances in Parkinsonism. Clinical Neurology and Neurosurgery, 82, 113-118.
22. Lal, S., Grassino, A., Thavundayil, J. X. & Dubrovsky, B. (1987) A simple method for the study of yawning in man induced by the dopamine receptor agonist apomorphine. Progress in Neuropsychopharmacology and Biological Psychiatry, 11, 223-228.
23. Leitgeb, N. (1990) Cyclotron resonance as a cause of biological effects of weak electric and magnetic fields? Biomedizinische Technologie, 35, 135-138.
24. Matsumoto, S., Yamada, K., Nagashima, M., Matsuo, N., Shirakawa, K. & Furukawa, T. (1989) Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats. Pharmacology Biochemistry and Behavior, 32, 815-818.
25. Mogilnicka, E. & Kilmek, V. (1977) Drugs affecting dopamine neurones and yawning behaviour. Pharmacology Biochemistry and Behavior, 7, 303-305.
26. Murofushi, T., Mizuno, M., Osanai, R. & Hayashida, T. (1991) Olfactory dysfunction in Parkinson's disease. Journal of Otolaryngology and Relates Specialities, 53, 143-146.
27. Nickell, W. T., Norman, A. B., Wyatt, L. M. & Shipley, M. T. (1991) Olfactory bulb DA receptors may be located on terminals of the olfactory nerve. NeuroReport, 2, 9-12.
28. Pearce, R. K., Hawkes, C. H. & Daniel, S. E. (1995) The anterior olfactory nucleus in Parkinson's disease. Movement Disorders, 10, 283-287.
29. Philpot, B. D., Men, D., McCarty, R. & Brunjes, P. C. (1998) Activity dependent regulation of dopamine content in the olfactory bulbs of naris-occluded rats. Neuroscience, 85, 969-977.
30. Quinn, N. P., Rossor, M. N. & Marsden, C. D. (1987) Olfactory threshold in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 50, 88-89.
31. Rollinson, R. D., Wiggins, W. S. & Gilligan, B. S. (1979) Drug-induced yawning successfully treated with pimozide. Archives of Neurology, 36, 253.
32. Roth, J., Radil, T., Ruzicka, E., Jech, R. & Tichy, J. (1998) Apomorphine does not influence olfactory threshold in Parkinson's disease. Functional Neurology, 13, 99-103.
33. Sandyk, R. (1992) Weak magnetic fields in the treatment of Parkinson's disease with the 'on-off' phenomenon. International Journal of Neuroscience, 66, 97-106.
34. Smith, S. D., McLeod, B. R., Liboff, A. R. & Cooksey, K. (1987) Calcium cyclotron resonance and diatom mobility. Bioelectromagnetics, 8, 215-227.
35. Serra, G., Collu, M. & Gessa, G. L. (1986) Dopamine receptors mediating yawning: are they autoreceptors? European Journal of Pharmacology, 120, 187-192.
36. Serra, G., Collu, M. & Cessa, G. L. (1987) Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390. Psychopharmacology, 91, 330-333.
37. Szechtman, H. (1984) Timing of yawns induced a small dose of apomorphine and its alteration by naloxone. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 743-746.
38. Ward, C. D., Hess, W. A. & Calne, D. B. (1983) Olfactory impairment in Parkinson's disease. Neurology, 33, 943-946.
39. 2+ channel in the brain. Life Sciences, 62, 1671-1675.
40. Wenning, G. K., Shephard, B., Hawkes, C., Petruckevitch, A., Lees, A. & Quinn, N. (1995) Olfactory function in atypical Parkinsonian syndromes. Acta Neurologica Scandinavica, 91, 247-250.
41. Yamada, K., Tanaka, M., Shibata, K. & Furukawa, T. (1986) Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats. Psychopharmacology, 90, 9-13.
42. Zarrindast, M. R., Toloui, V. & Hashemi, B. (1995a) Effect of GABA-ergic drugs on physostigmine-induced yawning in rats. Psychoparmacology (Berlin), 122, 297-300.
43. Zarrindast, M. R., Fatehi, F. & Mohagheghi-Badi, M. (1995b) Effects of adenosine agents on apomorphine-induced yawning in rats. Psychopharmacology, 122, 292-296.